Zhibo Zhao

机构：Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0009-0000-4784-3134

发表论文 6 篇 · 总被引 69 次 · h-index 4

代表论文

• Magic and mystery of microRNA‐32 (2021 · Journal of Cellular and Molecular Medicine · 被引 23)
• Targeting FDFT1 Reduces Cholesterol and Bile Acid Production and Delays Hepatocellular Carcinoma Progression Through the HNF4A/ALDOB/AKT1 Axis (2025 · Advanced Science · 被引 22)
• Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions (2023 · Cancer Science · 被引 13)
• N -glycosylation of SCAP exacerbates hepatocellular inflammation and lipid accumulation via ACSS2-mediated histone H3K27 acetylation (2024 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 10)
• Integrating bioinformatics and experimental validation to reveal a novel VRK score as a prognostic and therapeutic biomarker in hepatocellular carcinoma (2025 · Frontiers in Immunology · 被引 1)
• City-level ETI scores.xlsx (2023 · Figshare)